Health Care

Deal charge pushes drugmaker Eli Lilly to 1Q loss

Eli Lilly and Co. booked a $110.8 million loss in the first quarter, as the drugmaker absorbed a charge tied to its purchase of CoLucid Pharmaceuticals, but the insulin maker's bottom line beat expectations and it reaffirmed its 2017 forecast.

Is the US Postal Service Helping Deliver America's Drug Epidemic?

Tom Ridge, the former Homeland Security secretary and Pennsylvania governor, argues that the country’s growing drug problem can’t be cured until the U.S. closes loopholes in the postal system that allow illegal and deadly synthetic drugs to be shipped – undetected -- through the regular mail.